About: Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Sector: Healthcare
Industry: Medical Devices
Latest price: $2.00 (-0.50%)
SERANASDAQSera Prognostics Inc
Sera Prognostics Inc share price
SERA price activity
Last Price
$2.000
Change (24hr)
-0.01 USD (-0.50%)
Volume
8.07K
Volume (4w avg)
-
Open
$2.01
Day Range
$2.00 - $2.06
Previous Close
$2.01
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
SERA price performance
Delayed
09 Sep, 8:00 pm GMT+0
SERA Market Signals